EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression



RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression



Cancer Research 65(9): 3682-3690



Some oncogenes, such as activated Ras, cause the malignant transformation of lung cells. c-jun-NH2-kinase (JNK) activation is essential for the oncogenic function of these cells. In this study, we show that RASSF1A inhibits the growth of lung cancer cells by blocking the JNK pathway. The exogenous expression of RASSF1A suppressed JNIK phosphorylation, and cells stably transfected with RASSF1A showed reduced JNK and c-Jun phosphorylation and Cyclin D1 down-regulation. An in vitro kinase assay showed that the exogenous expression of RASSF1A inhibited JNK activity and that JNK activity suppression due to ectopically expressed RASSF1A was revived by RASSF1A siRNA treatment. Based on our data, we suggest that RASSF1A exerts a tumor-suppressing effect by blocking oncogene-mediated JNK activation in lung cells.

(PDF emailed within 0-6 h: $19.90)

Accession: 012477191

Download citation: RISBibTeXText

PMID: 15867363

DOI: 10.1158/0008-5472.CAN-04-2792



Related references

RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression. Journal of Cellular Physiology 226(9): 2360-2369, 2011

The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Molecular and Cellular Biology 22(12): 4309-4318, 2002

ARHGAP24 inhibits cell cycle progression, induces apoptosis and suppresses invasion in renal cell carcinoma. Oncotarget (): -, 2016

YSK2821, a newly synthesized indoledione derivative, inhibits cell proliferation and cell cycle progression via the cell cycle-related proteins by regulating phosphatidylinositol-3 kinase cascade in vascular smooth muscle cells. European Journal of Pharmacology 586(1-3): 74-81, 2008

Delayed cell cycle progression in selenoprotein W-depleted cells is regulated by a mitogen-activated protein kinase kinase 4-p38/c-Jun NH2-terminal kinase-p53 pathway. Journal of Biological Chemistry 287(33): 27371-9, 2012

Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells. International Journal of Cancer 122(7): 1512-1520, 2007

Expression of alpha CP-4 inhibits cell cycle progression and suppresses tumorigenicity of lung cancer cells. International Journal of Cancer 122(7): 1512-1520, 2008

Stem cell factor/c-kit up-regulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia. Journal of Biological Chemistry 275(33): 25572-6, 2000

Resveratrol inhibits cell cycle progression by targeting Aurora kinaseĀ A and Polo-like kinase 1 in breast cancer cells. Oncology Reports 35(6): 3696-3704, 2016

Inhibition of CXCL12/CXCR4 suppresses pulmonary arterial smooth muscle cell proliferation and cell cycle progression via PI3K/Akt pathway under hypoxia. Journal of Receptor and Signal Transduction Research 35(4): 329-339, 2016

Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochimica et Biophysica Acta 1310(1): 149-156, 1997

Protein kinase C inhibits the CAK-CDK2 cyclin-dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochimica et Biophysica Acta 1310(1): 149-156, 1996

Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circulation Research 97(8): 837-844, 2005

The Ras/protein kinase A pathway acts in parallel with the Mob2/Cbk1 pathway to effect cell cycle progression and proper bud site selection. Eukaryotic Cell 3(1): 108-120, 2004

The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Oncogene 26(12): 1820-1828, 2006